JAAD onlineA randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria
References (5)
The new antihistamines—desloratadine and levocetirizine: a review
J Drugs Dermatol
(2002)- et al.
Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU)
Int J Clin Pract
(2004)
There are more references available in the full text version of this article.
Cited by (10)
Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
2023, Journal of Allergy and Clinical Immunology: In PracticeTreatment of chronic spontaneous urticaria: Immunomodulatory approaches
2018, Clinical ImmunologyCitation Excerpt :Several randomized (placebo) controlled trials have proved their efficiency in CSU [31]. Cetirizine seems to be more effective than fexofenadine [32] and levocetirizine more effective than desloratadine [33]. However, rupatadine seems to be more effective than cetirizine [34], while levocetirizine seems to be more effective than rupatadine in another study [35].
Treatment of chronic urticaria: What's new?
2011, Revue Francaise d'AllergologieBrain histamine H<inf>1</inf> receptor occupancy after oral administration of desloratadine and loratadine
2019, Pharmacology Research and PerspectivesH1-antihistamines for chronic spontaneous urticaria
2014, Cochrane Database of Systematic Reviews
Supported by Lotus Pharmaceutical, Taipei, Taiwan.
Conflicts of interest: None declared.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.